Stock Market Stories and Insights

TTNP
  over a month ago at Macroaxis 
By Achuva Shats
Titan Pharma is scheduled to announce its earnings tomorrow. As many retail investors are getting excited about healthcare space, it is fair to recap Titan Pharma outlook under the recent economic conditions. We will evaluate why we are still optimistic in anticipation of a recovery.
LNN
  over a month ago at Macroaxis 
By Gabriel Shpitalnik
As many of us are excited about industrials space, it is fair to outline Lindsay Corp. We will evaluate why we are still confident in anticipation of a recovery. Is the firm valuation sustainable? Here I will cover a perspective on valuation of Lindsay to give you a better outlook on taking a position in this stock.
OMEX
  over a month ago at Macroaxis 
By Achuva Shats
Why analysts lower the firm buy or sell consensus to Hold? Odyssey Marine Expl is scheduled to announce its earnings tomorrow. As some millenniums are still trying to avoid industrials space, I will try to break down Odyssey Marine Expl a little further in order to understand its potential as a viable investment. We will evaluate if Odyssey Marine shares are reasonably priced given the current economic outlook. Analysts now have less confidence in Odyssey Marine as compared to a month ago. The current buy or sell recommendation of 1 analysts is Hold.
PAYX
  over a month ago at Macroaxis 
By Achuva Shats
As many baby boomers are indifferent towards industrials space, it makes sense to break down Paychex against current market trends. As expected, Paychex is starting to reaffirm its true potential as investors are becoming more and more confident in the future outlook. The returns on investing in Paychex and the market returns of the last few months appear uncorrelated. The appearance of strong basic indicators of the company suggests a short-term price swing for investors of Paychex. Paychex is scheduled to announce its earnings tomorrow. The upcoming quarterly report is expected on the 6th of April 2021.
GBX
  over a month ago at Macroaxis 
By Vlad Skutelnik
Greenbrier Companies Accrued Expenses Turnover is fairly stable at the moment as compared to the past year. Greenbrier Companies reported Accrued Expenses Turnover of 12.49 in 2020. Operating Margin is likely to rise to 5.85 in 2021, whereas Revenue Per Employee is likely to drop slightly above 217.4 K in 2021. As many of us are excited about industrials space, it is fair to break down Greenbrier Companies. We will check if it is still possible for Greenbrier Companies to minimize net losses this year. This post is to show some fundamental factors affecting Greenbrier Companies' products and services. I will also show how it may impact the investing outlook for Greenbrier Companies in May.
LNN
  over a month ago at Macroaxis 
By Vlad Skutelnik
It seems Lindsay Corp will continue to recover much faster as its share price surged up 0.47% today. The company current daily volatility is 2.11 percent, with a beta of 0.21 and an alpha of 0.41 over DOW. As many investors are getting excited about machinery, it is fair to outline Lindsay Corp. We will analyze why Lindsay Corp investors may still consider a stake in the business.
JEF
  over a month ago at Macroaxis 
By Raphi Shpitalnik
Considering the 90-day investment horizon Jefferies Financial is expected to generate 2.61 times more return on investment than the market. However, the company is 2.61 times more volatile than its market benchmark. It trades about 0.16 of its potential returns per unit of risk. The DOW is currently generating roughly 0.19 per unit of risk. While some of us are excited about financial services space, it makes sense to digest Jefferies Financial in greater detail to make a better estimate of its risk and reward. We will discuss if the expected returns on Jefferies Financial will justify its current volatility.
PAYX
  over a month ago at Macroaxis 
By Achuva Shats
It looks like Verisk Analytics will continue to recover much faster as its share price surged up 0.97% today to Paychex's 1.6201%. While some of us are excited about industrials space, we will evaluate how strong are Paychex and Verisk Analytics fundamentals. We are going to inspect some of the competitive aspects of both Paychex and Verisk.
PHA
  over a month ago at Macroaxis 
By Achuva Shats
Pharming Grp NV is scheduled to announce its earnings tomorrow. As some millenniums are still trying to avoid healthcare space, I will try to digest Pharming Grp NV a little further in order to understand its potential as a viable investment. What exactly are Pharming Grp shareholders getting in May?
ALRN
  over a month ago at Macroaxis 
By Raphi Shpitalnik
Aileron Therapeutics Market Capitalization is quite stable at the moment as compared to the past year. The company's current value of Market Capitalization is estimated at 46.03 Million. Tangible Asset Value is expected to rise to about 23.4 M this year, although the value of Earnings Before Interest Taxes and Depreciation Amortization EBITDA will most likely fall to (22.7 M). As many baby boomers are still indifferent towards healthcare space, it makes sense to outline Aileron Therapeutics. We will evaluate why recent Aileron Therapeutics price moves suggest a bounce in May. This post is to show some fundamental factors affecting Aileron Therapeutics' products and services. I will also disclose how it may impact the investing outlook for the firm in May.